191 related articles for article (PubMed ID: 25341731)
21. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R
Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182
[TBL] [Abstract][Full Text] [Related]
22. A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma.
Punj V; Matta H; Chaudhary PM
PLoS One; 2012; 7(5):e37498. PubMed ID: 22624040
[TBL] [Abstract][Full Text] [Related]
23. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction.
Bi X; Yang L; Mancl ME; Barnes BJ
J Interferon Cytokine Res; 2011 Apr; 31(4):373-82. PubMed ID: 21133648
[TBL] [Abstract][Full Text] [Related]
24. B-Raf-dependent expression of vascular endothelial growth factor-A in Kaposi sarcoma-associated herpesvirus-infected human B cells.
Akula SM; Ford PW; Whitman AG; Hamden KE; Bryan BA; Cook PP; McCubrey JA
Blood; 2005 Jun; 105(11):4516-22. PubMed ID: 15705790
[TBL] [Abstract][Full Text] [Related]
25. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S
Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists.
Vollmer S; Strickson S; Zhang T; Gray N; Lee KL; Rao VR; Cohen P
Biochem J; 2017 Jun; 474(12):2027-2038. PubMed ID: 28512203
[TBL] [Abstract][Full Text] [Related]
27. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
Schulz TF; Cesarman E
Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
[TBL] [Abstract][Full Text] [Related]
28. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
Kawagoe T; Sato S; Matsushita K; Kato H; Matsui K; Kumagai Y; Saitoh T; Kawai T; Takeuchi O; Akira S
Nat Immunol; 2008 Jun; 9(6):684-91. PubMed ID: 18438411
[TBL] [Abstract][Full Text] [Related]
29. Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function.
Williamson SJ; Nicol SM; Stürzl M; Sabbah S; Hislop AD
PLoS Pathog; 2016 Nov; 12(11):e1006042. PubMed ID: 27893813
[TBL] [Abstract][Full Text] [Related]
30. Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines.
Roy D; Sin SH; Damania B; Dittmer DP
Blood; 2011 Aug; 118(7):e32-9. PubMed ID: 21685375
[TBL] [Abstract][Full Text] [Related]
31. Genomic Landscape of Waldenström Macroglobulinemia.
Treon SP; Xu L; Liu X; Hunter ZR; Yang G; Castillo JJ
Hematol Oncol Clin North Am; 2018 Oct; 32(5):745-752. PubMed ID: 30190014
[TBL] [Abstract][Full Text] [Related]
32. Primary effusion lymphoma: secretome analysis reveals novel candidate biomarkers with potential pathogenetic significance.
Gloghini A; Volpi CC; Caccia D; Gualeni AV; Cilia AM; Carbone A; Bongarzone I
Am J Pathol; 2014 Mar; 184(3):618-30. PubMed ID: 24521760
[TBL] [Abstract][Full Text] [Related]
33. Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia.
Liu X; Hunter ZR; Xu L; Chen J; Chen JG; Tsakmaklis N; Patterson CJ; Castillo JJ; Buhrlage S; Gray N; Treon SP; Yang G
Br J Haematol; 2017 Jun; 177(5):808-813. PubMed ID: 27073043
[No Abstract] [Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
Carbone A; Gloghini A; Vaccher E; Cerri M; Gaidano G; Dalla-Favera R; Tirelli U
J Mol Diagn; 2005 Feb; 7(1):17-27. PubMed ID: 15681470
[TBL] [Abstract][Full Text] [Related]
35. Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond.
Magierowicz M; Tomowiak C; Leleu X; Poulain S
Hematol Oncol Clin North Am; 2018 Oct; 32(5):753-763. PubMed ID: 30190015
[TBL] [Abstract][Full Text] [Related]
36. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
[TBL] [Abstract][Full Text] [Related]
37. Primary effusion lymphoma involving the cerebrospinal fluid.
Moatamed NA; Song SX; Apple SK; Said JW
Diagn Cytopathol; 2012 Jul; 40(7):635-8. PubMed ID: 21381228
[TBL] [Abstract][Full Text] [Related]
38. Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature.
Zhang H; Yang XY; Hong T; Feldman T; Bhattacharyya PK
Acta Haematol; 2010; 123(4):237-41. PubMed ID: 20484888
[TBL] [Abstract][Full Text] [Related]
39. The death domain of IRAK-1: an oligomerization domain mediating interactions with MyD88, Tollip, IRAK-1, and IRAK-4.
Neumann D; Kollewe C; Resch K; Martin MU
Biochem Biophys Res Commun; 2007 Mar; 354(4):1089-94. PubMed ID: 17276401
[TBL] [Abstract][Full Text] [Related]
40. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature.
Wu W; Youm W; Rezk SA; Zhao X
Am J Clin Pathol; 2013 Aug; 140(2):258-73. PubMed ID: 23897264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
